You’ve spent months working on the asset. The clinical strategy has been debated. The data have been reviewed from every angle. The
When you read the Pharma news sites and analysis on LinkedIn about drug patent cliffs, you might think pharmaceutical companies are sitting
Intro Teams often fail not because of a lack of data, but because of research that confirms what they already believe. The
Asking challenging questions is essential when developing and commercializing new medicines. Whether you’re a doctor, patient, payer, or working commercially, challenging the
I got asked recently on a holiday by a friend “What do you do?”. Good question! Many projects I work on in
